Agilon Health (NYSE:AGL) Issues Quarterly Earnings Results, Beats Estimates By $3.20 EPS

Agilon Health (NYSE:AGL) announced its quarterly earnings data on Wednesday. The company reported $1.97 EPS for the quarter, beating analysts’ consensus estimates of ($1.23) by $3.20, FiscalAI reports. The firm had revenue of $1.52 billion during the quarter, compared to the consensus estimate of $1.46 billion. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%.

Here are the key takeaways from Agilon Health’s conference call:

• Agilon raised its 2026 outlook after beating third-quarter guidance, now expecting approximately $5.88 billion in revenue and $150 million in adjusted EBITDA. The stronger outlook reflects higher risk-adjustment revenue and favorable first-half medical cost development, though the company assumes cost trends around 7% for the rest of the year.
• Third-quarter adjusted EBITDA was $64 million, compared with a $91 million loss a year earlier, and the medical services expense ratio improved to 88.5% from 104%. Results benefited from risk-adjustment true-ups, favorable prior-year development, ACO performance, and lower-than-expected medical costs.
• ACO membership is expected to grow approximately 40%–50% in 2027, reaching about 160,000 members, driven largely by expanded MSSP partnerships. Management expects this growth to support improving baseline ACO adjusted EBITDA, while emphasizing a measured approach to new partnerships.
• Medicare Advantage membership was 454,000, down about 10% year over year, reflecting previously announced market exits tied to the company’s profitability-focused contracting strategy. Management also expects 2027 contracting benefits to be more modest than in 2026, when it re-contracted roughly 80% of membership.
• Management cited progress in clinical pathways and quality, including a 3% increase in gap closure and 4.2-star performance on contracted-plan quality measures. It said these programs can improve care and reduce avoidable costs, but noted that implementation and performance still vary across partners.

Agilon Health Price Performance

Shares of NYSE AGL traded up $7.83 on Wednesday, hitting $95.62. The company’s stock had a trading volume of 282,775 shares, compared to its average volume of 319,822. Agilon Health has a 12-month low of $7.48 and a 12-month high of $133.04. The company has a market capitalization of $1.61 billion, a price-to-earnings ratio of -6.70 and a beta of 3.10. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.08 and a quick ratio of 1.08. The stock has a 50 day moving average of $87.43 and a 200-day moving average of $65.50.

Analysts Set New Price Targets

Several research analysts have issued reports on AGL shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a research report on Monday, August 24th. Truist Financial set a $112.00 target price on shares of Agilon Health and gave the stock a “hold” rating in a research report on Thursday, August 6th. Wells Fargo & Company reiterated an “overweight” rating and issued a $146.00 price target (up from $141.00) on shares of Agilon Health in a report on Tuesday, August 11th. JPMorgan Chase & Co. upped their target price on shares of Agilon Health from $31.00 to $85.00 and gave the stock an “underweight” rating in a research report on Monday, August 24th. Finally, Benchmark reissued a “buy” rating and set a $140.00 price target (up from $95.00) on shares of Agilon Health in a research note on Thursday, August 6th. Six equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $102.25.

About Agilon Health

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company works with physician practices serving primarily older adults enrolled in Medicare Advantage and helps them manage the cost, quality and coordination of care for their patient populations.

Agilon provides a technology-enabled platform that includes population health analytics, clinical and administrative support, care coordination resources and practice-management capabilities.